Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liposarcoma × pemigatinib × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 1 Sarcoma 1 Lung Neoplasms 1 Liposarcoma 1 Gastrointestinal Stromal Tumors 1 Carcinoma, Transitional Cell 1 Carcinoma 1 Breast Neoplasms 1

Interventions

Doxorubicin 25 Radiotherapy 15 Ifosfamide 14 Trabectedin 10 pazopanib 6 ribociclib 5 pembrolizumab 5 Specimen Handling 5 Gemcitabine 5 Biopsy 5 palbociclib 4 Magnetic Resonance Spectroscopy 4 Docetaxel 4 Cyclophosphamide 4 Chemotherapy, Adjuvant 4 selinexor 3 liposomal doxorubicin 3 eribulin 3 X-Rays 3 Vincristine 3 Radiation 3 Neoadjuvant Therapy 3 Imatinib Mesylate 3 Filgrastim 3 Etoposide 3 toripalimab 2 temsirolimus 2 romidepsin 2 pegfilgrastim 2 cixutumumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06389799 2025-08-28

PERELI

Lund University Hospital

Phase 2 Recruiting

Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡